FDA Approved: DEXTROAMPHETAMINE — Supplemental Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a dextroamphetamine product from Cranbury Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)

Snippet

SUPPL AP for DEXTROAMPHETAMINE (DEXTROAMPHETAMINE)